These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15122443)

  • 21. Reliability and validity of the DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis (Greek version) and proposed modification.
    Printza A; Kalaitzi M; Bakirtzis C; Nikolaidis I; Proios H; Grigoriadis N
    Mult Scler Relat Disord; 2018 Jul; 23():62-68. PubMed ID: 29778042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Responsiveness of the Multiple Sclerosis International Quality of Life questionnaire to disability change: a longitudinal study.
    Baumstarck K; Butzkueven H; Fernández O; Flachenecker P; Stecchi S; Idiman E; Pelletier J; Boucekine M; Auquier P
    Health Qual Life Outcomes; 2013 Jul; 11():127. PubMed ID: 23895207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of quality of life among patients with multiple sclerosis: an Italian cross-sectional study.
    Patti F; Russo P; Pappalardo A; Macchia F; Civalleri L; Paolillo A;
    J Neurol Sci; 2007 Jan; 252(2):121-9. PubMed ID: 17188301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A multidimensional assessment of multiple sclerosis: relationships between disability domains.
    Provinciali L; Ceravolo MG; Bartolini M; Logullo F; Danni M
    Acta Neurol Scand; 1999 Sep; 100(3):156-62. PubMed ID: 10478578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MS-CANE: a computer-aided instrument for neurological evaluation of patients with multiple sclerosis: enhanced reliability of expanded disability status scale (EDSS) assessment.
    Cohen YC; Hassin-Baer S; Olmer L; Barishev R; Goldhammer Y; Freedman L; Mozes B
    Mult Scler; 2000 Oct; 6(5):355-61. PubMed ID: 11064447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Health-related quality of life in Japanese patients with multiple sclerosis.
    Niino M; Fukumoto S; Okuno T; Sanjo N; Fukaura H; Mori M; Ohashi T; Takeuchi H; Shimizu Y; Fujimori J; Kawachi I; Kira JI; Takahashi E; Miyazaki Y; Mifune N
    J Neurol; 2023 Feb; 270(2):1011-1018. PubMed ID: 36334134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Costs and quality of life of multiple sclerosis in Austria.
    Kobelt G; Berg J; Lindgren P; Plesnilla C; Baumhackl U; Berger T; Kolleger H; Vass K
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S14-23. PubMed ID: 17310339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validity and reliability of Persian version of Modified Fatigue Impact Scale (MFIS) questionnaire in Iranian patients with multiple sclerosis.
    Ghajarzadeh M; Jalilian R; Eskandari G; Ali Sahraian M; Reza Azimi A
    Disabil Rehabil; 2013 Aug; 35(18):1509-12. PubMed ID: 23237227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Costs and quality of life in multiple sclerosis in The Netherlands.
    Kobelt G; Berg J; Lindgren P; Anten B; Ekman M; Jongen PJ; Polman C; Uitdehaag B
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S55-64. PubMed ID: 17310343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [French validation of the Multiple Sclerosis International Quality of Life Questionnaire].
    Baumstarck-Barrau K; Pelletier J; Simeoni MC; Auquier P;
    Rev Neurol (Paris); 2011; 167(6-7):511-21. PubMed ID: 21420136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple Sclerosis Impact Scale (MSIS-29): relation to established measures of impairment and disability.
    Hoogervorst EL; Zwemmer JN; Jelles B; Polman CH; Uitdehaag BM
    Mult Scler; 2004 Oct; 10(5):569-74. PubMed ID: 15471375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disability, quality of life, personality, cognitive and psychological variables associated with fatigue in patients with multiple sclerosis.
    Fernández-Muñoz JJ; Morón-Verdasco A; Cigarán-Méndez M; Muñoz-Hellín E; Pérez-de-Heredia-Torres M; Fernández-de-las-Peñas C
    Acta Neurol Scand; 2015 Aug; 132(2):118-24. PubMed ID: 25644133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact and characteristics of quality of life in Japanese patients with multiple sclerosis.
    Kikuchi H; Mifune N; Niino M; Ohbu S; Kira J; Kohriyama T; Ota K; Tanaka M; Ochi H; Nakane S; Maezawa M; Kikuchi S
    Qual Life Res; 2011 Feb; 20(1):119-31. PubMed ID: 20700657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Functional Limitations Profile may be a valid, reliable and sensitive measure of disability in multiple sclerosis.
    Hutchinson J; Hutchinson M
    J Neurol; 1995 Oct; 242(10):650-7. PubMed ID: 8568526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Costs and quality of life of multiple sclerosis in Spain.
    Kobelt G; Berg J; Lindgren P; Izquierdo G; Sánchez-Soliño O; Pérez-Miranda J; Casado MA;
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S65-74. PubMed ID: 17310340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. eMSQOL-29: Prospective validation of the abbreviated, electronic version of MSQOL-54.
    Rosato R; Testa S; Bertolotto A; Scavelli F; Giovannetti AM; Confalonieri P; Patti F; Chisari CG; Lugaresi A; Pietrolongo E; Grasso MG; Rossi I; Toscano A; Loera B; Giordano A; Solari A
    Mult Scler; 2019 May; 25(6):856-866. PubMed ID: 29761738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validation of the functional assessment of multiple sclerosis quality of life instrument.
    Cella DF; Dineen K; Arnason B; Reder A; Webster KA; karabatsos G; Chang C; Lloyd S; Steward J; Stefoski D
    Neurology; 1996 Jul; 47(1):129-39. PubMed ID: 8710066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tried and tested: the psychometric properties of the multiple sclerosis impact scale (MSIS-29) in a population-based study.
    Gray O; McDonnell G; Hawkins S
    Mult Scler; 2009 Jan; 15(1):75-80. PubMed ID: 18829636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome measures for multiple sclerosis clinical trials: relative measurement precision of the Expanded Disability Status Scale and Multiple Sclerosis Functional Composite.
    Hobart J; Kalkers N; Barkhof F; Uitdehaag B; Polman C; Thompson A
    Mult Scler; 2004 Feb; 10(1):41-6. PubMed ID: 14760951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Difference between generic and multiple sclerosis-specific quality of life instruments regarding the assessment of treatment efficacy.
    Ozakbas S; Akdede BB; Kösehasanogullari G; Aksan O; Idiman E
    J Neurol Sci; 2007 May; 256(1-2):30-4. PubMed ID: 17379247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.